Loss of a Functionally and Structurally Distinct ld-Transpeptidase, LdtMt5, Compromises Cell Wall Integrity in Mycobacterium tuberculosis
- PMID: 26304120
- PMCID: PMC4646210
- DOI: 10.1074/jbc.M115.660753
Loss of a Functionally and Structurally Distinct ld-Transpeptidase, LdtMt5, Compromises Cell Wall Integrity in Mycobacterium tuberculosis
Abstract
The final step of peptidoglycan (PG) biosynthesis in bacteria involves cross-linking of peptide side chains. This step in Mycobacterium tuberculosis is catalyzed by ld- and dd-transpeptidases that generate 3→3 and 4→3 transpeptide linkages, respectively. M. tuberculosis PG is predominantly 3→3 cross-linked, and LdtMt2 is the dominant ld-transpeptidase. There are four additional sequence paralogs of LdtMt2 encoded by the genome of this pathogen, and the reason for this apparent redundancy is unknown. Here, we studied one of the paralogs, LdtMt5, and found it to be structurally and functionally distinct. The structures of apo-LdtMt5 and its meropenem adduct presented here demonstrate that, despite overall architectural similarity to LdtMt2, the LdtMt5 active site has marked differences. The presence of a structurally divergent catalytic site and a proline-rich C-terminal subdomain suggest that this protein may have a distinct role in PG metabolism, perhaps involving other cell wall-anchored proteins. Furthermore, M. tuberculosis lacking a functional copy of LdtMt5 displayed aberrant growth and was more susceptible to killing by crystal violet, osmotic shock, and select carbapenem antibiotics. Therefore, we conclude that LdtMt5 is not a functionally redundant ld-transpeptidase, but rather it serves a unique and important role in maintaining the integrity of the M. tuberculosis cell wall.
Keywords: Mycobacterium tuberculosis; antibiotics; biosynthesis; cell wall; enzyme kinetics; enzyme structure; peptidoglycan.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures
Similar articles
-
Structure and Inhibitor Specificity of L,D-Transpeptidase (LdtMt2) from Mycobacterium tuberculosis and Antibiotic Resistance: Calcium Binding Promotes Dimer Formation.AAPS J. 2018 Mar 9;20(2):44. doi: 10.1208/s12248-018-0193-x. AAPS J. 2018. PMID: 29524047
-
Binding and processing of β-lactam antibiotics by the transpeptidase LdtMt2 from Mycobacterium tuberculosis.FEBS J. 2017 Mar;284(5):725-741. doi: 10.1111/febs.14010. Epub 2017 Feb 8. FEBS J. 2017. PMID: 28075068
-
Molecular insight on the non-covalent interactions between carbapenems and L,D-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study.J Comput Aided Mol Des. 2018 Jun;32(6):687-701. doi: 10.1007/s10822-018-0121-2. Epub 2018 May 29. J Comput Aided Mol Des. 2018. PMID: 29845435
-
Fluorescent probes for investigating peptidoglycan biosynthesis in mycobacteria.Curr Opin Chem Biol. 2020 Aug;57:50-57. doi: 10.1016/j.cbpa.2020.04.006. Epub 2020 Jun 9. Curr Opin Chem Biol. 2020. PMID: 32531742 Review.
-
LD-transpeptidases: the great unknown among the peptidoglycan cross-linkers.FEBS J. 2022 Aug;289(16):4718-4730. doi: 10.1111/febs.16066. Epub 2021 Jun 22. FEBS J. 2022. PMID: 34109739 Review.
Cited by
-
Have we realized the full potential of β-lactams for treating drug-resistant TB?IUBMB Life. 2018 Sep;70(9):881-888. doi: 10.1002/iub.1875. Epub 2018 Jun 22. IUBMB Life. 2018. PMID: 29934998 Free PMC article. Review.
-
Non-classical transpeptidases yield insight into new antibacterials.Nat Chem Biol. 2017 Jan;13(1):54-61. doi: 10.1038/nchembio.2237. Epub 2016 Nov 7. Nat Chem Biol. 2017. PMID: 27820797 Free PMC article.
-
Peptidoglycan compositional analysis of Mycobacterium smegmatis using high-resolution LC-MS.Sci Rep. 2022 Jun 30;12(1):11061. doi: 10.1038/s41598-022-15324-1. Sci Rep. 2022. PMID: 35773428 Free PMC article.
-
Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01489-18. doi: 10.1128/AAC.01489-18. Print 2019 Feb. Antimicrob Agents Chemother. 2019. PMID: 30455232 Free PMC article.
-
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.Front Microbiol. 2017 Apr 25;8:681. doi: 10.3389/fmicb.2017.00681. eCollection 2017. Front Microbiol. 2017. PMID: 28487675 Free PMC article. Review.
References
-
- Walsh C. (2003) Antibiotics: Actions, Origins, Resistance, ASM Press, Washington, D. C.
-
- Wietzerbin J., Das B. C., Petit J. F., Lederer E., Leyh-Bouille M., Ghuysen J. M. (1974) Occurrence of d-alanyl-(d)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of mycobacteria. Biochemistry 13, 3471–3476 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
